Athenex Pharma Solutions

6 articles about Athenex Pharma Solutions

• 

  Clinical Catch-Up: September 13-17

  9/20/2021

  With a conference the size of ESMO, it’s impossible to cover all the exciting news, but here are many of the highlights. Here’s a look.
• 

  Clinical Catch-Up: May 17-21

  5/24/2021

  It was another busy week for clinical trial announcement. Here’s a look.
• 

  FDA Issues CRL Citing Safety, Data Issues for Athenex’s Oral Encequidar

  3/2/2021

  Cancer therapy company Athenex suffered a regulatory setback with the receipt of a complete response letter from the U.S. Food and Drug Administration.
• 

  Clinical Catch-Up: February 8-12

  2/15/2021

  It was a busy week for clinical trial announcements and news. Here’s a look.
• 

  FDA Action Alert: Urovant, Athenex, scPharmaceuticals and Vertex

  12/21/2020

  The U.S. FDA is plenty busy with COVID-19 vaccine Emergency Use Authorizations this month, but they’re also wrapping up the year with a few PDUFA dates for other therapies. Here’s a look.

• Athenex Pharma Solutions, An Athenex Company, Launches Three New Sterile Injectable Products From Its 503(B) Facility

  8/10/2017